The market for pneumococcal vaccines is one that is projected to continue rising quickly in the years to come. Numerous factors are contributing to this trend, such as an aging population, an increase in pneumococcal disease prevalence, growing vaccine awareness, and government measures to boost immunization rates.
At a compound annual growth rate (CAGR) of 6.7%, The Pneumonia Vaccine Market was estimated to be worth USD 10.23 billion in 2022. Vaccines against pneumococcal disease, which is brought on by the bacteria Streptococcus pneumoniae, are intended to either prevent or lessen the illness’s severity. Numerous symptoms, such as fever, coughing, chest pain, difficulty breathing, and exhaustion, can be brought on by pneumonia. Serious consequences, such sepsis and meningitis, can also result from pneumonia. Vaccinations against pneumococcal disease are advised for those who are more susceptible to the illness, such as infants and young children, adults who are older than 65, People with compromised immune systems, including those suffering from HIV/AIDS, cancer, or organ transplant recipients, People who suffer from long-term illnesses including diabetes, heart disease, or lung disease.
In terms of geography, the biggest markets for pneumococcal vaccinations are in North America, Europe, and Asia-Pacific. Growth in these regions is being driven by high vaccination rates, government backing for immunization campaigns, and the high prevalence of pneumococcal illness in North America and Europe. In the upcoming years, the Asia-Pacific market is anticipated to expand quickly due to rising vaccination awareness and government programs aimed at raising vaccination rates.
Request a Glimpse of Our Sample Report: https://wemarketresearch.com/sample-request/pneumonia-vaccine-market/398
Key Companies
Glaxosmithkline plc, LG Chem Ltd., Merck & Co., Inc., Panacea Biotec Limited, Pfizer Inc., Pnuvax Incorporated, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co., Ltd., SK Bioscience, and Walvax Biotechnology Co., Ltd.
Pneumonia Vaccine Market:- Segmental Analysis
By Product Type
Prevnar 13
Synflorix
Pneumovax23
By Vaccine Type
Pneumococcal Polysaccharide Vaccines
Pneumococcal Conjugate Vaccines
By Distribution Channel
Pharmacies
Community Clinics
Public Health Agencies
Country Scope
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria
Frequently Asked Questions
- What is PEST analysis, Ecosystem Analysis, Porter’s Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
- What are the top performing segments, and countries / regions of each of the markets?
- What is the market share (%) of Key Players?
- What are the technology trends shaping various markets?
- What factors will influence demand and supply trends across each markets during the forecast period?
- What is the COVID-19 impact on the market and how long will it take to recover?
- What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
- What is the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
Purchase this Report: https://wemarketresearch.com/purchase/pneumonia-vaccine-market/398?license=single
About We Market Research:
WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.
Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. WE MARKET RESEARCH is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.
Contact Us:
Mr. Robbin Joseph
Corporate Sales, USA
We Market Research
USA: +1-724-618-3925
Websites: https://wemarketresearch.com/
Email: [email protected]
Explore Our Blogs-
